mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.06 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.06 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.06 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |